Print Page

Products found to contain undeclared medicines

 
Canada: Foreign Product Alerts: Esbelin siloutte té, Esbelin siloutte Herbal Blend with L-Carnitine, Esbelder man, Esbelder fem, and Esbelder siloutte were found to contain undeclared sibutramine, N-desmethylsibutramine, and N-di-desmethylsibutramine
 
Health Canada warned consumers not to use Esbelin siloutte té, Esbelin siloutte Herbal Blend with L-Carnitine, Esbelder man, Esbelder fem, and Esbelder siloutte after they were found to contain undeclared sibutramine, N-desmethylsibutramine, and N-di-desmethylsibutramine. N-Desmethylsibutramin and N-di-Desmethylsibutramine are unauthorized substances that may be similar to sibutramine and may pose similar health risks. Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke. These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet. Consumers who have these products are advised not to use them, and should consult with a healthcare professional if they have concerns about their health related to the use of these products.

Please refer to the following website in Health Canada for details: http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../39293a-eng.php

In Hong Kong, the above products are not registered pharmaceutical products. Related news has been released by the US Food and Drug Administration (FDA) and was posted on the Drug Office website on 23 July 2013.


Ends/ Thursday, May 08, 2014
Issued at HKT 13:00
 
 
back